World Cardiovascular Device Market to Exceed USD 69.3 Bn by 2022, Projects Lucintel in Its Insightful Report Recently Added at MarketPublishers.com10 Aug 2017 • by Natalie Aster
LONDON – The world’s cardiovascular device market has promising future growth potential with lucrative opportunities in private and public hospitals. By 2022, this market is set to reach USD 69.3 billion in value, registering steady growth at a 4.3% CAGR during 2017-2022.
The key drivers of the cardiovascular device market growth comprise the escalating demand for minimally invasive surgery, rising geriatric population and elevating healthcare expenditures, amid others. Prominent trends that also have a considerable impact on the cardiovascular device market dynamics include expanding usage of bioresorbable stents, strong demand for portable heart monitoring devices and increasing adoption of transcatheter aortic valve replacement (TAVR) procedure.
The CRM sector is anticipated to keep on dominating the world’s cardiovascular device market through 2022. Growth in this sector is propelled by the rising usage of defibrillators primarily owing to its safety and cost-effectiveness.
Regionally, North America is expected to maintain the leading position in the global market for cardiovascular devices, majorly due to large patient pool and high adoption of advanced treatments in the region.
The insightful research report “Growth Opportunities in the Global Cardiovascular Device Market” worked out by Lucintel presents a detailed coverage of the market performance at different geographical scales, discusses the market scenario and highlights the market dynamics. It includes valuable info on the key factors shaping the market, discusses the key trends, opportunities and challenges. This research study features the competitive landscape, profiles the top companies, uncovers updated statistics, scrutinises the main market sectors and estimates the market shares. Besides, this report reviews the recent industry developments, comprises Porter’s five forces analysis, offers strategic recommendations and provides a comprehensive future outlook though 2022.
The major suppliers profiled in this research study: Medtronic Public Limited Company, Abbott Laboratories, Boston Scientific Corporation, Johnson & Johnson and Edwards Lifesciences Corporation.
Many other research studies by this publisher are provided at the Lucintel page at MarketPublishers.com.